##plugins.themes.academic_pro.article.main##

Abstract

This article covers the work devoted to the study of the features of the course, clinic and treatment of CAP

Keywords

pneumonia wax lungs

##plugins.themes.academic_pro.article.details##

How to Cite
Musaev F.T, Kenzhaev O.O, & Ergashev A.A. (2023). Features of the course, clinic and approaches to treatment of community-acquired pneumonia. Texas Journal of Medical Science, 18, 122–125. https://doi.org/10.62480/tjms.2023.vol18.pp122-125

References

  1. Mandell LA, Wunderink RG, Anzueto A, et al. American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–S72.
  2. Brown SM, Jones BE, Jephson AR, et al. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med. 2009;37:3010–3016.
  3. Phua J, See KC, Chan YH, et al. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax. 2009;64:598–603
  4. Chalmers JD, Taylor JK, Mandal P, et al. Validation of the Infectious Diseases Society of America/American Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis. 2011;53:503–511
  5. Charles P., Fine M., Ramirez J. et al. Validation of SMART-COP: a pneumoniae severity assessment tool for predicting with patients will need intensive respiratory or inotropic support (IRIS). In: 47th ICAAC. Chicago; 2007:Abstr: L1156a.